Lipocine
LPCN
#10590
Rank
ยฃ13.39 M
Marketcap
ยฃ1.62
Share price
-1.14%
Change (1 day)
-32.88%
Change (1 year)

Revenue for Lipocine (LPCN)

Revenue in 2026 (TTM): ยฃ1.47 Million

According to Lipocine's latest financial reports the company's current revenue (TTM ) is ยฃ1.5 Million. In 2025 the company made a revenue of ยฃ1.46 Million a decrease over the revenue in the year 2024 that were of ยฃ8.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lipocine from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ1.47 M0.8%
2025 ยฃ1.46 M-83.55%
2024 ยฃ8.92 M-498.78%
2023 -ยฃ2.24 Million-641.43%
2022 ยฃ0.41 M-96.54%
2021 ยฃ11.95 M
2020 N/A-100%
2019 ยฃ0.12 M-62.69%
2018 ยฃ0.33 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
ยฃ1.72 B 114,790.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ3.33 B 221,587.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
ยฃ16.18 M 977.21%๐Ÿ‡บ๐Ÿ‡ธ USA